Once a powerful profit-machine, big pharma is stumbling ,the threat of further government intervention, drying product pipelines, fierce competition from generic manufacturers, consumer concerns about safety, and false marketing claims is forcing leaders to revisit operations to secure top line Growth. So leaders such as Judith Marquis, Group VP Genzyme, Jeffrey Nye, Chief Medical Officer...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pharmaceutical Industry Set to Emerge as winners in the Healthcare Reform
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account